BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22306368)

  • 1. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.
    Lesseur C; Gilbert-Diamond D; Andrew AS; Ekstrom RM; Li Z; Kelsey KT; Marsit CJ; Karagas MR
    Toxicol Lett; 2012 Apr; 210(1):100-6. PubMed ID: 22306368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk.
    Andrew AS; Mason RA; Kelsey KT; Schned AR; Marsit CJ; Nelson HH; Karagas MR
    Toxicol Lett; 2009 May; 187(1):10-4. PubMed ID: 19429237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
    Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
    Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between Arsenic (+3 Oxidation State) Methyltransferase Genetic Polymorphisms and Methylation Capacity of Inorganic Arsenic].
    Agusa T; Kunito T; Minh Tue N; Thi Mai Lan V; Binh Minh T; Thi Kim Trang P; Fujihara J; Takeshita H; Takahashi S; Hung Viet P; Tanabe S; Iwata H
    Nihon Eiseigaku Zasshi; 2015; 70(3):186-96. PubMed ID: 26411936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.
    Karagas MR; Andrew AS; Nelson HH; Li Z; Punshon T; Schned A; Marsit CJ; Morris JS; Moore JH; Tyler AL; Gilbert-Diamond D; Guerinot ML; Kelsey KT
    Hum Genet; 2012 Mar; 131(3):453-61. PubMed ID: 21947419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction.
    Pierce BL; Tong L; Argos M; Gao J; Farzana J; Roy S; Paul-Brutus R; Rahaman R; Rakibuz-Zaman M; Parvez F; Ahmed A; Quasem I; Hore SK; Alam S; Islam T; Harjes J; Sarwar G; Slavkovich V; Gamble MV; Chen Y; Yunus M; Rahman M; Baron JA; Graziano JH; Ahsan H
    Int J Epidemiol; 2013 Dec; 42(6):1862-71. PubMed ID: 24536095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.
    Beebe-Dimmer JL; Iyer PT; Nriagu JO; Keele GR; Mehta S; Meliker JR; Lange EM; Schwartz AG; Zuhlke KA; Schottenfeld D; Cooney KA
    Environ Health; 2012 Jun; 11():43. PubMed ID: 22747749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. As3MT and GST Polymorphisms Influencing Arsenic Metabolism in Human Exposure to Drinking Groundwater.
    González-Martínez F; Sánchez-Rodas D; Varela NM; Sandoval CA; Quiñones LA; Johnson-Restrepo B
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan.
    Hsu LI; Chen WP; Yang TY; Chen YH; Lo WC; Wang YH; Liao YT; Hsueh YM; Chiou HY; Wu MM; Chen CJ
    J Biomed Sci; 2011 Jul; 18(1):51. PubMed ID: 21798077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair dye use and risk of bladder cancer in the New England bladder cancer study.
    Koutros S; Silverman DT; Baris D; Zahm SH; Morton LM; Colt JS; Hein DW; Moore LE; Johnson A; Schwenn M; Cherala S; Schned A; Doll MA; Rothman N; Karagas MR
    Int J Cancer; 2011 Dec; 129(12):2894-904. PubMed ID: 21678399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire.
    Applebaum KM; Karagas MR; Hunter DJ; Catalano PJ; Byler SH; Morris S; Nelson HH
    Environ Health Perspect; 2007 Aug; 115(8):1231-6. PubMed ID: 17687452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of arsenic-induced cardiovascular disease susceptibility with genetic polymorphisms.
    Al-Forkan M; Wali FB; Khaleda L; Alam MJ; Chowdhury RH; Datta A; Rahman MZ; Hosain N; Maruf MF; Chowdhury MAQ; Hasan NKMM; Shawon II; Raqib R
    Sci Rep; 2021 Mar; 11(1):6263. PubMed ID: 33737636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
    Andrew AS; Karagas MR; Hamilton JW
    Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of GST polymorphisms and arsenic related skin lesions.
    McCarty KM; Ryan L; Houseman EA; Williams PL; Miller DP; Quamruzzaman Q; Rahman M; Mahiuddin G; Smith T; Gonzalez E; Su L; Christiani DC
    Environ Health; 2007 Feb; 6():5. PubMed ID: 17284320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
    Törüner GA; Akyerli C; Uçar A; Aki T; Atsu N; Ozen H; Tez M; Cetinkaya M; Ozçelik T
    Arch Toxicol; 2001 Oct; 75(8):459-64. PubMed ID: 11757669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.
    Ritambhara ; Tiwari S; Vijayaraghavalu S; Kumar M
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2707-2714. PubMed ID: 31554367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain.
    Cantor KP; Villanueva CM; Silverman DT; Figueroa JD; Real FX; Garcia-Closas M; Malats N; Chanock S; Yeager M; Tardon A; Garcia-Closas R; Serra C; Carrato A; Castaño-Vinyals G; Samanic C; Rothman N; Kogevinas M
    Environ Health Perspect; 2010 Nov; 118(11):1545-50. PubMed ID: 20675267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.